14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $85.60 $94.15 Thursday, 29th Feb 2024 BMRN stock ended at $86.28. This is 2.40% less than the trading day before Wednesday, 28th Feb 2024. During the day the stock fluctuated 3.45% from a day low at $86.02 to a day high of $88.99.
90 days $85.60 $99.55
52 weeks $76.02 $101.48

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
2024-02-29 $88.80 $88.99 $86.02 $86.28 2 603 953
2024-02-28 $89.82 $90.24 $88.32 $88.40 1 153 600
2024-02-27 $90.64 $92.16 $90.09 $90.68 1 224 961
2024-02-26 $90.93 $91.19 $88.11 $90.10 1 419 313
2024-02-23 $90.94 $94.15 $89.48 $91.24 3 632 448
2024-02-22 $89.30 $90.44 $88.63 $89.97 1 618 604
2024-02-21 $88.67 $89.20 $87.41 $88.54 1 220 755
2024-02-20 $88.14 $90.26 $87.53 $88.67 1 338 869
2024-02-16 $88.30 $89.49 $87.85 $88.77 1 041 685
2024-02-15 $86.11 $88.73 $86.11 $88.30 1 941 690
2024-02-14 $86.24 $86.81 $85.71 $86.01 1 218 295
2024-02-13 $87.15 $87.39 $85.60 $86.13 910 982
2024-02-12 $88.47 $89.16 $88.10 $88.18 1 092 557
2024-02-09 $88.28 $88.64 $87.83 $88.46 1 355 295
2024-02-08 $89.77 $90.18 $87.47 $88.15 1 076 292
2024-02-07 $89.46 $91.06 $88.50 $89.66 2 218 452
2024-02-06 $88.12 $90.05 $87.58 $89.80 1 483 967
2024-02-05 $87.76 $88.33 $87.08 $87.72 1 121 406
2024-02-02 $87.91 $88.43 $87.29 $88.11 837 377
2024-02-01 $87.72 $88.87 $87.26 $88.74 1 186 819
2024-01-31 $89.67 $90.01 $87.64 $88.08 1 061 324
2024-01-30 $91.59 $91.59 $89.43 $89.62 1 369 752
2024-01-29 $91.00 $91.78 $89.47 $91.78 675 330
2024-01-26 $91.62 $91.65 $90.37 $90.87 1 093 164
2024-01-25 $92.51 $92.92 $90.70 $91.25 1 188 532
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT